Lonza Potelligent CHOK1SV host cell line
Potelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.
The cell line retains the features of a high-productivity cell line (robust, high-yielding, scalable) and the bioprocess platform for CHOK1SV is repeatable in the new cell line.
Antibodies produced by the new cell line: exhibit enhanced antibody dependent cellular cytotoxicity (ADCC) even with the low-ADCC allotype of CD16, overcoming CD16 polymorphism; can exert potent cytotoxic effects when their target antigen is low; work in whole blood; and retain required features of antibodies, such as Protein A binding.
Phone: 1300 657508
EpigenTek EpiQuik CUT&RUN m6A RNA Enrichment (MeRIP) Kit
The kit is a complete set of optimised buffers and reagents designed to enrich an RNA fragment...
Cayman Chemical Off-Patent Drug Screening Library (96-Well)
Featuring a curated collection of FDA-approved compounds that are no longer covered under...
Norgen Biotek Bacterial EV Isolation Kit
The Bacterial EV Isolation Kit enables researchers to isolate extracellular vesicles directly...
